NASDAQ:ISPC iSpecimen (ISPC) Stock Price, News & Analysis $1.25 +0.04 (+2.88%) Closing price 04/25/2025 03:59 PM EasternExtended Trading$1.24 -0.01 (-0.80%) As of 04/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About iSpecimen Stock (NASDAQ:ISPC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get iSpecimen alerts:Sign Up Key Stats Today's Range$1.21▼$1.2850-Day Range$1.06▼$2.1852-Week Range$1.02▼$11.80Volume22,705 shsAverage Volume414,068 shsMarket Capitalization$3.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewiSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.Read More… iSpecimen Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks16th Percentile Overall ScoreISPC MarketRank™: iSpecimen scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for iSpecimen. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of iSpecimen is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iSpecimen is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiSpecimen has a P/B Ratio of 0.06. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about iSpecimen's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.70% of the float of iSpecimen has been sold short.Short Interest Ratio / Days to CoveriSpecimen has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iSpecimen has recently increased by 65.62%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiSpecimen does not currently pay a dividend.Dividend GrowthiSpecimen does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.70% of the float of iSpecimen has been sold short.Short Interest Ratio / Days to CoveriSpecimen has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in iSpecimen has recently increased by 65.62%, indicating that investor sentiment is decreasing significantly. News and Social Media3.3 / 5News Sentiment1.87 News SentimentiSpecimen has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for iSpecimen this week, compared to 0 articles on an average week.Search InterestOnly 2 people have searched for ISPC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iSpecimen insiders have not sold or bought any company stock.Percentage Held by Insiders12.20% of the stock of iSpecimen is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 13.62% of the stock of iSpecimen is held by institutions.Read more about iSpecimen's insider trading history. Receive ISPC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iSpecimen and its competitors with MarketBeat's FREE daily newsletter. Email Address ISPC Stock News HeadlinesiSpecimen Inc. (ISPC) Stock Price, News, Quote & History - Yahoo FinanceFebruary 22, 2025 | finance.yahoo.comiSpecimen Stock Hits 52-Week Low at $1.81 Amid Market ChallengesFebruary 12, 2025 | msn.comClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...April 26, 2025 | American Alternative (Ad)iSpecimen stock hits 52-week low at $1.96 amid market challengesFebruary 3, 2025 | msn.comiSpecimen Shares Rise After Securring Virus SuppliersJanuary 16, 2025 | marketwatch.comiSpecimen Strengthens Leadership and Expands Cancer Research FocusDecember 20, 2024 | tipranks.comiSpecimen Appoints Robert Lim as New CEODecember 12, 2024 | markets.businessinsider.comiSpecimen Inc. Reports Earnings Amid Financial ChallengesNovember 9, 2024 | markets.businessinsider.comSee More Headlines ISPC Stock Analysis - Frequently Asked Questions How have ISPC shares performed this year? iSpecimen's stock was trading at $2.65 at the beginning of the year. Since then, ISPC stock has decreased by 52.8% and is now trading at $1.25. View the best growth stocks for 2025 here. How were iSpecimen's earnings last quarter? iSpecimen Inc. (NASDAQ:ISPC) posted its quarterly earnings results on Monday, April, 14th. The company reported ($6.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.00) by $2.28. The firm had revenue of $1.48 million for the quarter, compared to analyst estimates of $2.98 million. iSpecimen had a negative trailing twelve-month return on equity of 139.25% and a negative net margin of 91.66%. When did iSpecimen IPO? iSpecimen (ISPC) raised $20 million in an initial public offering (IPO) on Thursday, June 17th 2021. The company issued 2,200,000 shares at $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO. How do I buy shares of iSpecimen? Shares of ISPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iSpecimen own? Based on aggregate information from My MarketBeat watchlists, some other companies that iSpecimen investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and Braze (BRZE). Company Calendar Last Earnings4/14/2025Today4/26/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial physical research Sub-IndustryBusiness Services Current SymbolNASDAQ:ISPC CIK1558569 Webispecimen.com Phone781-301-6700FaxN/AEmployees60Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($18.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,100,000.00 Net Margins-91.66% Pretax Margin-91.65% Return on Equity-139.25% Return on Assets-73.97% Debt Debt-to-Equity RatioN/A Current Ratio0.74 Quick Ratio0.74 Sales & Book Value Annual Sales$9.29 million Price / Sales0.34 Cash FlowN/A Price / Cash FlowN/A Book Value$21.47 per share Price / Book0.06Miscellaneous Outstanding Shares2,497,000Free Float846,000Market Cap$3.12 million OptionableNot Optionable Beta1.77 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:ISPC) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iSpecimen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iSpecimen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.